Second-quarter venture capital investments are up nearly 85% compared to last year, a recent low for funding of med-tech companies in the U.S. Burl Gilyard Star Tribune August 5th at 2:31 PM CDT Endogenex CEO Stacey Pugh holds the ReCET medical device, a catheter used for treatment of Type 2 diabetes, at the company’s Plymouth headquarters. (Renée Jones Schneider / Star Tribune)

Integrity Orthopaedics Announces Closure of Series B Financing Minneapolis, MN (April 30, 2024) – Integrity Orthopaedics, Inc., a company pioneering next generation solutions for soft tissue repair, has successfully closed on a Series B financing of $20.6 million.  The financing was co-led by Piper Sandler Merchant Banking and an undisclosed existing investor.  The company intends to use the capital to